Lemborexant
From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Lua error in Module:Infobox at line 314: malformed pattern (missing ']').
Lemborexant (INN) (code name E-2006) is a dual antagonist of the orexin OX1 and OX2 receptors which is under development by Eisai for the treatment of insomnia.[1] [2][3] As of December 2014, it is in phase II clinical trials.[4]
See also
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
External links
<templatestyles src="Asbox/styles.css"></templatestyles>
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
Categories:
- Pages with reference errors
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- Carboxamides
- Hypnotics
- Orexin antagonists
- Organofluorides
- Pyrimidines
- Pyridines
- Nervous system drug stubs
Hidden categories: